August 01, 2008
AJP CME Course for August 2008: Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Self-Assessment Quiz - Expired

Did you know? You can add a subscription now to earn CME Credits!

Xanomeline has in vitro selectivity for which of the following receptors?
Which of the following side effects were typically reported more frequently in the xanomeline treated subjects compared to those receiving placebo?
Xanomeline treatment was associated with statistically significant improvement on which of the following measures?